Walgreens Boots Alliance (WBA) Set to Announce Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) will be posting its quarterly earnings results before the market opens on Thursday, March 28th. Analysts expect Walgreens Boots Alliance to post earnings of $0.84 per share for the quarter. Walgreens Boots Alliance has set its FY 2024 guidance at 3.200-3.500 EPS and its FY24 guidance at $3.20-$3.50 EPS.Investors interested in listening to the company’s conference call can do so using this link.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.04. Walgreens Boots Alliance had a net margin of 0.40% and a return on equity of 10.48%. The company had revenue of $36.70 billion for the quarter, compared to analyst estimates of $34.95 billion. During the same period in the prior year, the firm posted $1.16 EPS. The company’s quarterly revenue was up 9.9% on a year-over-year basis. On average, analysts expect Walgreens Boots Alliance to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Walgreens Boots Alliance Stock Up 0.2 %

Walgreens Boots Alliance stock opened at $20.63 on Tuesday. The company has a quick ratio of 0.30, a current ratio of 0.66 and a debt-to-equity ratio of 0.27. Walgreens Boots Alliance has a 12-month low of $19.68 and a 12-month high of $36.58. The firm’s fifty day moving average is $21.85 and its 200 day moving average is $22.31. The company has a market capitalization of $17.79 billion, a PE ratio of 31.26, a PEG ratio of 1.27 and a beta of 0.73.

Walgreens Boots Alliance Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 12th. Investors of record on Tuesday, February 20th were given a dividend of $0.25 per share. The ex-dividend date was Friday, February 16th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 4.85%. Walgreens Boots Alliance’s payout ratio is presently 151.52%.

Wall Street Analysts Forecast Growth

WBA has been the topic of a number of research reports. Barclays initiated coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price on the stock. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. SVB Leerink lowered their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. Finally, HSBC restated a “reduce” rating and set a $20.00 price objective (down previously from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $25.75.

Check Out Our Latest Report on Walgreens Boots Alliance

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Valerie B. Jarrett bought 4,456 shares of the business’s stock in a transaction on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the transaction, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. In other news, Director Valerie B. Jarrett purchased 4,456 shares of the stock in a transaction dated Monday, January 29th. The shares were purchased at an average cost of $22.44 per share, with a total value of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares in the company, valued at approximately $99,992.64. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Nancy M. Schlichting sold 15,209 shares of the stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $23.05, for a total transaction of $350,567.45. The disclosure for this sale can be found here. Company insiders own 17.40% of the company’s stock.

Institutional Investors Weigh In On Walgreens Boots Alliance

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. raised its stake in Walgreens Boots Alliance by 4.6% in the first quarter. BlackRock Inc. now owns 63,406,129 shares of the pharmacy operator’s stock valued at $2,192,584,000 after purchasing an additional 2,797,885 shares in the last quarter. Morgan Stanley raised its stake in Walgreens Boots Alliance by 10.7% in the fourth quarter. Morgan Stanley now owns 11,974,220 shares of the pharmacy operator’s stock valued at $447,357,000 after purchasing an additional 1,155,331 shares in the last quarter. Moneta Group Investment Advisors LLC raised its stake in Walgreens Boots Alliance by 84,503.5% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 8,325,830 shares of the pharmacy operator’s stock valued at $311,053,000 after purchasing an additional 8,315,989 shares in the last quarter. Legal & General Group Plc raised its stake in Walgreens Boots Alliance by 10.7% in the fourth quarter. Legal & General Group Plc now owns 7,356,393 shares of the pharmacy operator’s stock valued at $192,076,000 after purchasing an additional 710,807 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Walgreens Boots Alliance by 7.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 5,132,750 shares of the pharmacy operator’s stock worth $229,794,000 after acquiring an additional 358,403 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Company Profile

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.